Duchenne muscular dystrophy: Focus on pharmaceutical and nutritional interventions

This publication has 40 references indexed in Scilit:

• First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant
  Neuromuscular Disorders, 2006
• Duchenne Muscular Dystrophy
  Pediatrics in Review, 2006
• Persistent and improved functional gain in mdx dystrophic mice after treatment with L‐arginine and deflazacort
  The FASEB Journal, 2006
• Green tea extract and its major polyphenol (−)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy
  American Journal of Physiology-Cell Physiology, 2006
• A Multidisciplinary Evaluation of the Effectiveness of Cyclosporine A in Dystrophic Mdx Mice
  The American Journal of Pathology, 2005
• Taurine and Skeletal Muscle Disorders
  Neurochemical Research, 2004
• Detection of glucocorticoid-like activity in traditional Chinese medicine used for the treatment of Duchenne muscular dystrophy
  Neuromuscular Disorders, 2003
• Enhanced Dystrophic Progression in mdx Mice by Exercise and Beneficial Effects of Taurine and Insulin-Like Growth Factor-1
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species
  The American Journal of Clinical Nutrition, 2002
• Administration of Chinese Herbal Medicines Facilitates the Locomotor Activity in Dystrophin-Deficient Mice
  The American Journal of Chinese Medicine, 2001